January 22, 2010 | Quintiles and invivodata, inc., have announced a collaboration agreement to transform the way Patient Reported Outcomes (PRO) are used in clinical research to speed drug development. The collaborative arrangement connects invivodata’s PRO consulting, technology, and service solutions to the full suite of Quintiles’ clinical services, providing integrated processes and deliverables. It will reduce study complexity and cost as redundant services are removed throughout all phases of drug development. The agreement solidifies an ongoing collaborative effort between the companies, with invivodata providing its ePRO solutions in more than 20 joint studies to date. Read more.